Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol

BACKGROUND: Mobile health (mHealth) is increasingly advocated for diabetes management. It is unclear if mobile applications are effective in improving glycaemic control, clinical outcomes, quality of life and overall patient satisfaction in patients with type 2 diabetes (T2DM). A new mobile applicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Suleiman, Noor, Alkasem, Meis, Al Amer, Zaina, Salameh, Obada, Al-Thani, Noora, Hamad, Mohammad Khair, Baagar, Khaled, Abdalhakam, Ibrahem, Othman, Manal, Dughmosh, Ragae, Al-Mohanadi, Dabia, Al Sanousi, Ali, Bashir, Mohammed, Chagoury, Odette, Taheri, Shahrad, Abou-Samra, Abdul-Badi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205079/
https://www.ncbi.nlm.nih.gov/pubmed/35710428
http://dx.doi.org/10.1186/s13063-022-06334-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205079/
https://www.ncbi.nlm.nih.gov/pubmed/35710428
http://dx.doi.org/10.1186/s13063-022-06334-5

Ejemplares similares